Shanghai-Hong Kong Zhongke
Biopharmaceutical preclinical research and development service company
Company News
Company News
2023-08-08
Activity Review | HKISI-CAS Visited Anling Shenzhen for Inspection and ExchangeOn August 8, 2023, A delegation from Centre for Regenerative Medicine and Health, Hong Kong Institute of Science Innovation, Chinese Academy of Sciences.(hereinafter referred to as the inspection group) visited Anling Biomed (Shenzhen) Co., ...
Read more +2023-07-29
ZSHK appeared at the 2023 BT Summit, and Anling Shenzhen was invited to attend major platform launches, General Manager Jin Yi gave a keynote report.From July 27th to 29th, the 2023 Shenzhen International Biomedical Industry Innovation and Development Conference was successfully held at the Yanzihu International Convention and Exhibition Center in Pingshan, Shenzhen. The theme of the con...
Read more +2023-07-26
The ZSHK COO Jin Yi was requested to speak at the 2023 Shenzhen International Biomedical Industry Innovation and Development ConferenceFrom July 27th to 29th, 2023, Anling Biomed (Shenzhen) Co., Ltd. (hereinafter referred to as Anling Shenzhen), a wholly owned subsidiary of ZSHK Laboratories Limited. (hereinafter referred to as ZSHK), was invited to participate in the 2023 ...
Read more +2023-07-17
Highlights Review | Summary of ZSHK's Activities in the First Half of 2023:From February 27th to March 3rd, ZSHK accompanied a delegation from the China Pharmaceutical Innovation and Research Development Association (PhIRDA) on a visit to Hong Kong and Singapore. They also held a reception dinner in Hong Kong, wher...
Read more +2023-06-08
Activity review The Inauguration Ceremony of Anling Biomed (Shenzhen) GLP Center was Successfully HeldOn the afternoon of June 8, 2023, the Anling Biomed (Shenzhen) GLP Center officially commenced its operation. Anling Biomed, carrying the love and expectations of its customers, set sail to fulfill the expectations by providing quality servi...
Read more +